Fresenius SE & Co. KGaA (FSNUY)
OTCMKTS · Delayed Price · Currency is USD
13.59
+0.17 (1.27%)
Nov 21, 2025, 4:00 PM EST
Fresenius SE & Co. KGaA Market Cap
Fresenius SE & Co. KGaA has a market cap or net worth of $30.63 billion as of November 24, 2025. Its market cap has increased by 52.44% in one year.
Market Cap
30.63B
Enterprise Value
44.26B
Revenue
26.33B
Ranking
n/a
PE Ratio
22.84
Stock Price
$13.59
Market Cap Chart
Since April 23, 1997, Fresenius SE & Co. KGaA's market cap has increased from 2.17B to 30.63B, an increase of 1,311.75%. That is a compound annual growth rate of 9.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 30.40B | 55.11% |
| Dec 30, 2024 | 19.60B | 12.16% |
| Dec 29, 2023 | 17.48B | 10.60% |
| Dec 30, 2022 | 15.80B | -29.41% |
| Dec 30, 2021 | 22.38B | -13.65% |
| Dec 30, 2020 | 25.92B | -17.36% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 824.30M |
| Elite Pharmaceuticals | 555.46M |
| Glass House Brands | 520.88M |
| Tian'an Technology Group | 386.45M |
| CytoDyn | 384.62M |
| Northwest Biotherapeutics | 382.71M |
| American Oncology Network | 346.66M |
| Nika Pharmaceuticals | 311.89M |